Stem Cell and Peptide Therapy for Joint Pain in Raleigh
Stem cell and peptide therapy for joint pain are regenerative medicine approaches that use the body's own biological mechanisms — stem cells, growth factors, and signaling peptides — to support tissue repair and reduce inflammation in damaged joints, under direct physician supervision.
What Is Regenerative Joint Therapy?
Joint pain from osteoarthritis, sports injuries, repetitive strain, or age-related cartilage degradation affects millions of Americans. Conventional treatment typically follows a predictable path: over-the-counter anti-inflammatories, physical therapy, corticosteroid injections, and eventually — when those stop working — surgical consultation.
Regenerative joint therapy introduces a different option at the point where conventional approaches plateau but before surgery becomes the only remaining choice. Rather than masking pain or replacing the joint, regenerative approaches aim to support the body's own repair processes at the site of injury.
This is not a claim that regenerative therapy replaces surgery. Severe structural damage — a fully torn ligament, bone-on-bone degeneration with mechanical locking, or joint instability that affects daily function — may require surgical evaluation and intervention. Regenerative therapy is an option patients may explore for mild-to-moderate joint degeneration, chronic inflammatory conditions, and injuries where the body's healing response has stalled.
At Peptide Therapy Raleigh, Dr. Vaidya evaluates each patient's imaging, clinical presentation, and functional goals to determine whether regenerative approaches may be appropriate — or whether a surgical referral is the more responsible recommendation.
How Peptide and Stem Cell Therapy May Support Joint Health
Stem Cells and Tissue Repair
Stem cell therapy for joints involves concentrating the patient's own regenerative cells and delivering them directly to the site of damage via image-guided injection. These cells may support the body's repair processes by reducing local inflammation, signaling surrounding tissue to initiate healing, and potentially contributing to cartilage and soft tissue regeneration.
Research in this area is active and evolving. Some clinical studies suggest improvements in pain scores, function, and cartilage thickness following stem cell treatment for knee osteoarthritis. Other studies show mixed results depending on the severity of degeneration, the cell source, and the preparation technique. Dr. Vaidya discusses the current evidence directly with each patient during consultation.
Peptides and Inflammatory Modulation
Peptides like BPC-157 work through a different mechanism. Rather than introducing new cells, BPC-157 is a signaling peptide that may modulate the inflammatory response at the site of injury, support angiogenesis (new blood vessel formation), and promote tendon and ligament healing. Research suggests BPC-157 may be particularly relevant for soft tissue injuries — tendinitis, ligament sprains, and muscle tears — where the body's healing has plateaued.
When combined, stem cells and peptides may complement each other: stem cells addressing the structural repair component while peptides support the healing environment around the injury site.
Treatments We Offer
Stem Cell Therapy — Starting at $1,500/treatment
Stem cell therapy at PTR uses concentrated regenerative cells delivered via precision-guided injection to the affected joint. The procedure is performed in-office and typically takes 1–2 hours. Most patients experience minimal downtime, with gradual improvement over 4–12 weeks as the biological response develops.
Stem cell therapy for joint pain is investigational and not FDA-approved for this indication. Results vary based on the nature and severity of joint damage.
→ Learn more about Stem Cell TherapyBPC-157 — Starting at $200/month
BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in human gastric juice. Research suggests it may support healing of tendons, ligaments, muscles, and other connective tissues through anti-inflammatory and pro-angiogenic mechanisms. It is typically administered via subcutaneous injection near the site of injury or systemically.
BPC-157 is not FDA-approved and is used off-label under physician supervision.
→ Learn more about BPC-157Joint Injections — Pricing varies by protocol
Dr. Vaidya may recommend regenerative joint injections that combine multiple biological components — such as platelet-rich plasma (PRP) with peptide support — based on the specific joint condition and treatment goals.
Regenerative joint injections are investigational for most orthopedic indications. Protocols are customized based on imaging and clinical evaluation.
Important note: Severe structural damage — including advanced bone-on-bone arthritis, complete ligament tears, or mechanical joint instability — may require surgical evaluation. Dr. Vaidya includes orthopedic referral as part of the clinical assessment when indicated and will not recommend regenerative therapy in cases where surgery is the more appropriate intervention.
What to Expect
Initial Evaluation
Your first visit includes a thorough orthopedic and functional assessment. Dr. Vaidya reviews existing imaging (MRI, X-ray), orders additional diagnostics if needed, and evaluates your pain patterns, functional limitations, and treatment history. This evaluation determines whether regenerative therapy is a reasonable option or whether referral to an orthopedic surgeon is more appropriate.
Treatment Day
For stem cell procedures, the appointment typically takes 1–2 hours. The injection is performed using image guidance for precision placement. Most patients experience mild soreness at the injection site for 2–5 days. BPC-157 protocols involve daily subcutaneous injections that patients self-administer at home after instruction.
Recovery and Follow-Up
Improvement from regenerative joint therapy is gradual. Most patients notice the initial response at 4–6 weeks, with continued improvement over 3–6 months. Dr. Vaidya schedules follow-up appointments to assess progress, adjust protocols, and determine whether additional treatments are indicated. Some patients benefit from a series of treatments rather than a single session.
Frequently Asked Questions
Can stem cell therapy replace knee surgery?
Stem cell therapy is not a replacement for surgery. It is an option patients with mild-to-moderate joint degeneration may explore. Patients with severe structural damage, bone-on-bone arthritis with mechanical symptoms, or complete ligament tears should undergo orthopedic evaluation. Dr. Vaidya assesses each patient individually and recommends surgical referral when clinically appropriate.
How long do results from stem cell joint therapy last?
Published data on duration of benefit varies widely — from 6 months to several years — depending on the joint, the severity of damage, and the patient's activity level. Dr. Vaidya discusses realistic expectations based on your specific condition during consultation.
Is BPC-157 effective for joint pain?
Research suggests BPC-157 may support healing of tendons, ligaments, and soft tissues through anti-inflammatory mechanisms. Clinical evidence is primarily from preclinical studies, with growing but still limited human data. BPC-157 is not FDA-approved and is used off-label. Dr. Vaidya evaluates whether BPC-157 is appropriate based on the nature of your joint condition.
Is the procedure painful?
Most patients report mild to moderate discomfort during injection, similar to a standard joint injection. Local anesthesia is used to minimize pain during the procedure. Post-procedure soreness typically resolves within 2–5 days.
How much does regenerative joint therapy cost?
Stem cell therapy starts at $1,500 per treatment. BPC-157 protocols start at $200 per month. Total cost depends on the number of treatments, the joint involved, and whether combination protocols are recommended. Insurance does not typically cover regenerative therapies. Full pricing is discussed during your consultation.
Medical Disclaimer: Stem Cell Therapy and BPC-157 is administered under the direct supervision of Dr. Bhavna Vaidya, MD. Stem Cell Therapy and BPC-157 is used off-label and is not FDA-approved for the conditions described. Individual results vary. Please schedule a consultation to discuss whether this therapy is appropriate for your health goals.
Ready to Explore Joint Pain Therapy?
Book a free 10-minute Peptide Discovery Call to discuss your health goals with our team.
Book Your Discovery CallOr call (919) 322-2844
Board-Certified in Family Practice and Anti-Aging Medicine. Practicing since 2005. Dr. Vaidya leads both Regenesis MD and Peptide Therapy Raleigh, offering integrative medicine combining peptide therapy, stem cells, hormone optimization, and medical aesthetics under one roof.
Read full bio →Nearby Locations
Our clinic at 8020 Creedmoor Rd, Raleigh, NC 27613 serves patients throughout the Triangle area.